Psychiatry

Your Article Summary

See Latest Articles

What Makes Patients with Fibromyalgia Feel Better? Correlations Between Patient Global Impression of Improvement and Changes in Clinical Symptoms and Function: A Pooled Analysis of 4 Randomized Placebo-controlled Trials of Duloxetine
Journal of Rheumatology, 10/16/09

Hudson JI et al. – In addition to pain reduction, what makes patients with FM feel better may include improvement in fatigue, physical functioning, mood, and impact on daily living. An assessment of these domains may be important in clinical trials of FM and in the management of patients with FM.

• Data were pooled from 4 randomized, double–blind, placebo–controlled studies of duloxetine in patients with fibromyalgia (FM).
• Variables included in the analyses were those that assessed symptoms in FM domains of pain, fatigue, sleep, cognitive difficulties, emotional well–being, physical function, and impact on daily living.
• The association of endpoint PGI–I with changes from baseline in individual variables was assessed using Pearson product–moment correlations (r).

• Changes in pain variables and interference of symptoms with the ability to work were highly correlated with endpoint Patient Global Impression of Improvement (PGI–I).
• Moderate correlation with endpoint PGI–I included changes in variables that assessed physical functioning, depression, anxiety, fatigue, and several variables related to impact on daily living.
• Independent predictor variables of endpoint PGI–I identified by stepwise linear regression included assessments for pain, physical function, vitality, anxiety, social function, and tender point thresholds.

Related Articles

See all related articles

Duloxetine for treating painful neuropathy or chronic pain
Cochrane Reviews, 10/08/09    Relevance Score: 67%

Milnacipran, a serotonin and norepinephrine reuptake inhibitor: a novel treatment for fibromyalgia
International Journal of Clinical Rheumatology, 10/19/09    Relevance Score: 65%

Developments in the scientific and clinical understanding of fibromyalgia
Arthritis Research & Therapy, 10/16/09    Relevance Score: 65%

Fibromyalgia: The diagnosis and pharmacologic treatment
European Journal of Pain, 11/12/09    Relevance Score: 64%

Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09    Relevance Score: 47%

Today in Neuro/Psych Pharmacol...keeping you current

Receive free subspecialty "5-minute updates" via email

Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09

Catatonia and Its Treatment
Schizophrenia Bulletin, 12/15/09

Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09

 See all of Neuro/Psych Pharmacol

Today in Neuro/Psych Pharmacol...keeping you current

Receive free subspecialty "5-minute updates" via email

Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09

Catatonia and Its Treatment
Schizophrenia Bulletin, 12/15/09

Atomoxetine Attenuates Dextroamphetamine Effects in Humans
American Journal of Drug & Alcohol Abuse, 12/14/09

 See all of Neuro/Psych Pharmacol

Today in Pain Management...keeping you current

Receive free subspecialty "5-minute updates" via email

Identifying experimental methods to determine the effect of pain on attention: a review of pain, caffeine, alcohol and nicotine studies
Human Psychopharmacology: Clinical and Experimental, 12/15/09

A Mind-Body Program for Older Adults with Chronic Low Back Pain: Results of a Pilot Study
Pain Medicine, 12/15/09

A Comparison of Common Screening Methods for Predicting Aberrant Drug-Related Behavior among Patients Receiving Opioids for Chronic Pain Management
Pain Medicine, 12/15/09

 See all of Pain Management